medmix Past Earnings Performance

Past criteria checks 0/6

medmix's earnings have been declining at an average annual rate of -40.2%, while the Medical Equipment industry saw earnings growing at 1.9% annually. Revenues have been growing at an average rate of 3.6% per year.

Key information

-40.2%

Earnings growth rate

-52.0%

EPS growth rate

Medical Equipment Industry Growth-9.5%
Revenue growth rate3.6%
Return on equity-0.2%
Net Margin-0.4%
Next Earnings Update26 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How medmix makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BATS-CHIXE:MEDXZ Revenue, expenses and earnings (CHF Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24480-211627
31 Mar 24483-111726
31 Dec 23487011926
30 Sep 23481511325
30 Jun 234751010824
31 Mar 234761110524
31 Dec 224771210324
30 Sep 224782110223
30 Jun 224803110123
31 Mar 22468379823
31 Dec 21457449623
30 Sep 21435369223
30 Jun 21414288923
31 Mar 21382198522
31 Dec 20351108120
31 Dec 19421258623
31 Dec 18454528523

Quality Earnings: MEDXZ is currently unprofitable.

Growing Profit Margin: MEDXZ is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: MEDXZ is unprofitable, and losses have increased over the past 5 years at a rate of 40.2% per year.

Accelerating Growth: Unable to compare MEDXZ's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MEDXZ is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (39.9%).


Return on Equity

High ROE: MEDXZ has a negative Return on Equity (-0.21%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 12:32
End of Day Share Price 2024/12/23 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

medmix AG is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christoph GretlerCredit Suisse
Eugen PergerResearch Partners AG